On Tuesday, 2482 stocks advanced, 1521 declined and 154 remained unchanged on Bombay Stock Exchange with advance decline ratio of 1.63 indicating a positive closing. After a sustained period of bullish strength, Moneylife’s Market Breadth Indicators continued remain neutral territory. The trend of the major indices on Tuesday’s trading is given in the table below.
On NSE, 50 securities advanced and closed at a new 52-week high whereas 55 securities sank to close at their new 52-week lows. In sectoral indices, Nifty Pharma, Nifty FMCG and Nifty IT were among the biggest losers. Nifty Auto and Nifty Metal were among the biggest gainers.
SpiceJet (-0.93%) recorded zero Level 1 safety findings in DGCA audits over the past year, affirming its operational integrity. The airline also renewed its IOSA certification in March 2025, valid till March 2027, reinforcing its adherence to global safety standards. SpiceJet reiterated safety as its top priority under regulatory and international norms.
Texmaco Rail & Engineering (-0.38%) secured a Rs73.12 crore contract from Central Railway for electrification infrastructure. The scope includes design, supply, erection, testing, and commissioning of a 110 KV/25KV AC traction substation, a sub-sectioning post (SSP), and associated works. The project also involves upgrading 132 KV transmission lines using HTLS conductors to improve power efficiency. Execution is scheduled over 24 month.
Dixon Technologies (-0.90%) signed a Master Services Agreement with Tech Mahindra to implement AI-powered Industry 4.0 automation across its manufacturing and R&D facilities. Under the partnership, Tech Mahindra will deliver end-to-end digital transformation solutions including smart factory services, robotics, system integration, and data analytics. The initiative aims to enhance Dixon’s operational agility, precision, and efficiency, while enabling proactive decision-making and intelligent manufacturing environments
Power Grid Corporation of India (-0.90%) received board approval to raise up to Rs5,000 crore via private placement of taxable bonds under its 82nd series for FY25-26. Base size of Rs1,000 crore with a green shoe option of Rs4,000 crore and it is an unsecured, non-convertible, non-cumulative, redeemable at par after 10 years.
Aurionpro Solutions (+2.45%) acquired Melbourne-based InfraRisk to expand its Integro lending suite and strengthen its presence in Australia, Singapore, and the UK. The move enhances Aurionpro’s banking and TIG verticals, leveraging InfraRisk’s 15+ years of lending tech expertise.
TCS (-0.34%) renewed and expanded its five-year contract with Weatherford International to drive AI-led digital transformation across finance, supply chain, and HR operations. . The partnership builds on a seven-year relationship, with prior initiatives reducing Weatherford’s total cost of ownership by around 50% across key operations.
Cipla’s (-1.01%) Bommasandra facility in Bengaluru received a VAI classification from USFDA following a cGMP inspection conducted from 26–30 May 2025. The outcome reflects minor observations with no regulatory action required.
Gokaldas Exports (-8.77%) reported Q1 FY26 net profit of Rs 41.5 crore, up 52.6% y-o-y, driven by margin expansion and cost efficiencies. Revenue rose 2.6% y-o-y to Rs966.8 crore, while EBITDA grew 30% to Rs97.3 crore with operating profit margins improving to 10.2% from 8.1%,
BLS International (+3.94%) reported Q1FY26 net profit of Rs181 crore, up 50% y-o-y, with revenue rising 44% to Rs711 crore. Operating profit grew 53% y-o-y to Rs204 crore, with margins expanding 171 bps to 28.7%, driven by consolidation of iDATA and Aadifidelis.
Adani Ports (-2.22%) reported Q1 FY26 net profit of Rs3,311 crore, up 6.5% y-o-y, with revenue rising 31% to Rs9,126 crore. Growth was driven by a 2x jump in logistics revenue and 2.9x rise in marine services, with cargo volumes up 11% y-o-y to 121 MMT.
Exide Industries (-1.55%) posted Q1 FY26 net profit of Rs275 crore, up 24% y-o-y, with revenue rising 5.9% to Rs4,695 crore. Operating profit stood at Rs548 crore, with margins improving to 12.2% from 11.5%, aided by better mix and cost optimisation.
Eris Lifesciences (+0.28%) reported Q1 FY26 net profit of Rs 106 crore, up 31% y-o-y, driven by strong growth in core therapies and branded formulations. Revenue rose 17% y-o-y to Rs600.5 crore, while operating profit grew 24% to Rs178.7 crore with margins expanding 170 bps to 29.8%.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below:
